Breast cancer is the most common form of cancer in women worldwide. Thanks to persistent research, here at Vanderbilt and around the world, doctors are better able to identify high-risk patients and offer a number of strategies to help with early detection, treatment and even prevention in some cases.
Right now, CTTC has 13 active innovations, which are at various stages of the commercialization process, that in the future could have significant impact on the detection, diagnosis and treatment of breast cancer. While these technologies are not available to consumers yet, it is our goal to move them from the research labs to industry partners for further development so they can do what they are supposed to do – help people.
Currently, Vanderbilt’s list of active breast cancer-related technologies includes:
- Molecular Profiles for Subtyping Triple Negative Breast Cancer
- Gene Signature Predicts Systemic Metastasis and Death in Prostate and Breast Cancer Patients
- Method to Treat Breast Cancer by Targeting Cancer Stem Cells, Tumor Microenvironment and Metastasis
- Long Term Estrogen Deprived (LTED) Human Breast Cancer Cell Lines
- Device for 3D, Real Time and Intraoperative Surgical Margin Evaluation
- Breast Tumor Margin Detection System Using Spatially Offset Raman Spectroscopy
- Device Using Raman Spectroscopy to Evaluate Margins Around Tumors
- Biochemical and Genetic Analysis for Prediction of Breast Cancer Risk
- Identification of Kinases that Compensate for PI3K Inhibition in Breast Cancer Cells
- Web-based Breast Cancer Risk Calculator Based on a Model for Estrogen Metabolism
- Image Guidance System for Breast Cancer Surgeries
- RNAi Technology to Selectively Inhibit mTORC2 in Breast Cancer
- Quantifying Breast Tissue Changes with Spectrally Selective MRI and MRS
These technologies are at the forefront of breast cancer research; the men and women who discovered them are leaders in the field. This October, Breast Cancer Awareness Month, we want to highlight the technologies in our current pipeline, recognize the Vanderbilt scientists and clinicians working to develop these technologies, and spotlight innovations that have been licensed to industry and are positively impacting society.